SCHEMBL25580376

SCHEMBL25580376

c1ccc(-c2ccccc2-c2c(-c3ccccc3)cccc2-c2ccccc2N(c2cccc(-c3ccc4ccccc4c3)c2)c2ccc3oc4ccccc4c3c2)cc1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 1/20 0.32
▸ HSD17B2 P37059 1/20 0.32
▸ CASP3 P42574 1/20 0.31
▸ SENP7 Q9BQF6 1/20 0.31
▸ SENP6 Q9GZR1 1/20 0.31
▸ ANO1 Q5XXA6 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ MAPT P10636 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ CASP1 P29466 1/20 0.31
▸ CASP7 P55210 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ PLA2G10 O15496 1/20 0.31
▸ PLA2G2A P14555 1/20 0.31
▸ PLA2G4A P47712 1/20 0.31
▸ GPR84 Q9NQS5 1/20 0.30
▸ PGR P06401 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25580253 0.96 ANO1 (0.33) HSD17B1HSD17B2ANO1ALDH1A1MAPT
SCHEMBL25580375 0.94 HCRTR1 (0.33) HSD17B1HSD17B2ALDH1A1MAPTGPR84
SCHEMBL25578975 0.94 ANO1 (0.34) HSD17B1HSD17B2CASP3SENP7SENP6
SCHEMBL25580293 0.94 MAPT (0.33) ALDH1A1MAPTKDM4EHPGDALOX15
SCHEMBL25580745 0.92 CASP3 (0.33) HSD17B1HSD17B2CASP3SENP7SENP6
SCHEMBL25581017 0.92 GPR84 (0.34) HSD17B1HSD17B2CASP3SENP7SENP6
SCHEMBL24919331 0.92 CASP3 (0.34) HSD17B1HSD17B2CASP3SENP7SENP6
SCHEMBL27273899 0.92 CASP3 (0.34) HSD17B1HSD17B2CASP3SENP7SENP6
SCHEMBL23225045 0.91 ANO1 (0.35) HSD17B1HSD17B2CASP3SENP7SENP6
SCHEMBL27273900 0.91 CASP3 (0.34) HSD17B1HSD17B2CASP3SENP7SENP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230180597-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ESR2 HSD17B1 3017/4885HSD17B2 2771/4885CASP3 3448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback